•ImmunityBio faces a securities class action lawsuit after the FDA issued a warning letter regarding misleading efficacy claims for its product Anktiva.
•The news caused IBRX shares to plunge 21%, resulting in a loss of approximately $2 billion in market capitalization.
•Eos Energy reported EPS of $0.12, significantly beating analyst estimates of a $0.22 loss per share.
•Quarterly revenue reached $56.96 million, exceeding the estimated $54.32 million and showing substantial growth from $10.46 million in the prior year.
•The company announced a strategic partnership with Cerberus to form Frontier Power USA, focusing on grid-scale energy storage.
•Federal Pacific announced its largest contract ever from Bloom Energy to supply medium-voltage switchgear and engineering services for a large-scale AI data center project.
•Levi & Korsinsky initiated an investigation into Hub Group following the disclosure of material accounting errors that led to a 12.5% share price drop.
•ZoomInfo is facing an investigation after a sharp downward revision to its FY 2026 guidance caused shareholders to lose 33% of their investment value.
•CDW Corporation announced a $1 billion increase to its share repurchase program, bringing the total available authorization to approximately $1.484 billion.
•Pfizer received marketing authorization from the European Commission to expand the label of its Hympavzi therapy to include adolescents across all 27 EU member states.
•Pembina Pipeline received TSX approval to renew its normal course issuer bid to purchase up to five percent of its issued and outstanding common shares.
•Coty Inc. is facing a securities class action lawsuit on behalf of investors who acquired common stock between November 5, 2025, and February 4, 2026.
•The lawsuit follows a Q2 2026 earnings report detailing operational issues and the abrupt departure of CEO Sue Y. Nabi.
•The company withdrew its 2026 financial guidance following a surprise profit decline.
•Global Asset Management Group announced progress on a $92 million acquisition and redevelopment of the former Memorial Hospital campus in Rhode Island.
•The company has initiated the process to uplist its shares to the OTCQB market.
•DOMA Perpetual owns approximately 7.5% of Pacira BioSciences' outstanding common stock and is urging shareholders to vote for its three independent board candidates.
•DOMA accuses Pacira management of gross negligence and misleading investors regarding risks to EXPAREL, advocating for a strategic sale of the company.
•Hagens Berman filed a new class action lawsuit against Super Micro and its executives alleging the concealment of an illegal scheme to sell billions in AI servers.
•The complaint alleges the company sold servers powered by Nvidia chips that were subject to U.S. export restrictions.
•Boston Fed President Susan Collins stated that the central bank might need to raise interest rates if inflation pressures broaden in the coming months.
•Collins noted she is closely watching how households' inflation expectations have drifted higher.
•A U.S. appeals court rejected a Puerto Rican lender's challenge against the New York Fed's decision to cut off its access to the central banking system.
•The U.S. Energy Information Administration expects utility-scale solar power generation to surpass coal for the first time in 2026 within the Texas grid.
•Metaplanet's CEO Simon Gerovich announced a delay in the launch of perpetual preferred shares due to regulatory and infrastructure challenges in Japan.
•GoPro announced it has retained investment bank Houlihan Lokey to serve as its financial advisor to evaluate a potential sale and other strategic alternatives.